I had to split time between yesterday’s Advisory Committee meeting and my day job, so I can’t profess to having seen every presentation and testimony yesterday. But based on what I did see and what I gleaned through other sources (thank you Twitter and The Street’s excellent live blog), here are a few scattered thoughts on … More Scattered thoughts on Sarepta’s AdComm
I spent the end of last week stuck in the Bermuda Triangle of traffic between JFK, LaGuardia, and Manhattan up in Times Square for BioCentury’s Future Leaders in the Biotech Industry conference. This was yet another pitch-and-partner conference, but this one had presenting companies running the full gamut–from preclinical companies to public companies with products already on the market. Rather than takeaways, … More Superlatives from the Future Leaders in the Biotech Industry conference
Last week was a North Carolina-centered conference binge. First was the NC Biotech Life Sciences Forum, which featured a panel discussion on venture philanthropy. The next two days were filled with a mix of biotech companies, investors, and a Nobel laureate at the CED Life Science Conference. And perhaps the best part of all–this was all right in my backyard (strange … More Takeaways from an NC-centered conference week
Last week I had the pleasure of visiting New York City to attend the 2015 Life Sciences Summit: a fantastic mix of investors, early stage companies, and development-focused academics. In addition to sneaking in a run along the Hudson and taking my first Uber (or is it Uber ride? Or hailing my first Uber? I guess … More 4 takeaways from the Life Sciences Summit
Thanks to the kind folks at PhD Over Easy for letting me share some of my career experiences and opinions! You can check out my post (and find your way to a lot of other great content) here.
Welcome! After some careful consideration, I’ve decided that I’m mentally and emotionally prepared to take the next step in my social media development and start sharing my perspective in >140 character quips. I anticipate this blog being a mix of current event commentary and researched posts focusing on the following general topics: The science of the biotech/pharma industry, including … More We have liftoff